Literature DB >> 15663493

Randomized, double-blind, placebo-controlled pilot study to assess the value of free radical scavengers in reducing inflammation induced by cryotherapy.

J E Gach1, F Humphreys, J Berth-Jones.   

Abstract

The inflammation which follows cryotherapy is a significant disadvantage of this therapeutic modality. To date, the only treatment shown to reduce this inflammation is application of topical corticoids. We have therefore conducted a pilot study to investigate whether pretreatment with the free radical scavengers, vitamins C and E might alleviate the signs and symptoms of inflammation following liquid nitrogen cryotherapy of common warts. We undertook a randomized, double-blind, placebo-controlled, parallel group study. We recruited 40 adult patients, of whom 38 returned for evaluation. Treatments comprised vitamin C (2000 mg) and vitamin E (800 IU) daily or matching placebo for 7 days prior to cryotherapy to a hand wart. Oedema volume, erythema level, pain intensity and the presence or absence of blistering were assessed 24 h after cryotherapy. There were no significant differences between the two treatment groups in any of the parameters assessed. This study yielded no suggestion of benefit from the use of pretreatment with free radical scavengers in conjunction with liquid nitrogen cryotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15663493     DOI: 10.1111/j.1365-2230.2004.01694.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

Review 1.  Topical treatments for cutaneous warts.

Authors:  Chun Shing Kwok; Sam Gibbs; Cathy Bennett; Richard Holland; Rachel Abbott
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

2.  The effect of a cryotherapy gel wrap on the microcirculation of skin affected by chronic venous disorders.

Authors:  Teresa J Kelechi; Martina Mueller; Jane G Zapka; Dana E King
Journal:  J Adv Nurs       Date:  2011-05-19       Impact factor: 3.187

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.